Log In
BCIQ
Print this Print this
 

MCLA-117

  Manage Alerts
Collapse Summary General Information
Company Merus N.V.
DescriptionHuman bispecific IgG antibody targeting C-type lectin domain family 12 member A (CLEC12A; CLL1) and CD3
Molecular Target C-type lectin domain family 12 member A (CLEC12A) (CLL1) ; CD3
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/04/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today